Brief: Syngene International Signs Research And Development Agreement With GSK
26/03/2018 05:45
March 26 (Reuters) - Syngene International Ltd SYNN.NS :
* SAYS CO SYNGENE INTERNATIONAL SIGNS RESEARCH AND
DEVELOPMENT
AGREEMENT WITH GSK
* SAYS CO'S SCIENTISTS TO WORK WITH GSK TO ADVANCE DRUG
DISCOVERY
IN MULTIPLE THERAPEUTIC AREAS
Source text - http://bit.ly/2G8MdoY
Further company coverage: SYNN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syngene International
See all newsIndia's Syngene advances after quarterly profit rebound
Brief: Syngene International Sept-Quarter Consol Profit 322 Million Rupees
India's Syngene International slides to 6-year low on Q1 loss, full-year forecast
Brief: Syngene International Posts June-Quarter Consol Loss 90 Million Rupees
Brief: Syngene International Says Granted Tax Refund Of 86.2 Million Rupees